These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 17416263)
1. Economic implications of newborn screening for cystic fibrosis: a cost of illness retrospective cohort study. Sims EJ; Mugford M; Clark A; Aitken D; McCormick J; Mehta G; Mehta A; Lancet; 2007 Apr; 369(9568):1187-95. PubMed ID: 17416263 [TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A; Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267 [TBL] [Abstract][Full Text] [Related]
3. More evidence to favour newborn screening for cystic fibrosis. Wilcken B; Gaskin K Lancet; 2007 Apr; 369(9568):1146-7. PubMed ID: 17416243 [No Abstract] [Full Text] [Related]
4. Cost effectiveness of newborn screening for cystic fibrosis: a simulation study. Nshimyumukiza L; Bois A; Daigneault P; Lands L; Laberge AM; Fournier D; Duplantie J; Giguère Y; Gekas J; Gagné C; Rousseau F; Reinharz D J Cyst Fibros; 2014 May; 13(3):267-74. PubMed ID: 24238947 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program. Lee DS; Rosenberg MA; Peterson A; Makholm L; Hoffman G; Laessig RH; Farrell PM J Pediatr; 2003 Jun; 142(6):617-23. PubMed ID: 12838188 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of 4 neonatal screening strategies for cystic fibrosis. van den Akker-van Marle ME; Dankert HM; Verkerk PH; Dankert-Roelse JE Pediatrics; 2006 Sep; 118(3):896-905. PubMed ID: 16950979 [TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for cystic fibrosis: an economic analysis. Nielsen R; Gyrd-Hansen D Health Econ; 2002 Jun; 11(4):285-99. PubMed ID: 12007162 [TBL] [Abstract][Full Text] [Related]
8. [A short-term diagnostic and economic impact model of neonatal screening for cystic fibrosis]. Rasch A; Perleth M Klin Padiatr; 2011 Mar; 223(2):96-103. PubMed ID: 21305445 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of newborn screening for cystic fibrosis determined with real-life data. van der Ploeg CP; van den Akker-van Marle ME; Vernooij-van Langen AM; Elvers LH; Gille JJ; Verkerk PH; Dankert-Roelse JE; J Cyst Fibros; 2015 Mar; 14(2):194-202. PubMed ID: 25213034 [TBL] [Abstract][Full Text] [Related]
10. Neonatal screening for cystic fibrosis does not affect time to first infection with Pseudomonas aeruginosa. Baussano I; Tardivo I; Bellezza-Fontana R; Forneris MP; Lezo A; Anfossi L; Castello M; Aleksandar V; Bignamini E Pediatrics; 2006 Sep; 118(3):888-95. PubMed ID: 16950978 [TBL] [Abstract][Full Text] [Related]
11. Direct healthcare costs in the first 2 years of life: A comparison of screened and clinically diagnosed children with cystic fibrosis - The Irish comparative outcomes study of CF (ICOS). Somerville R; Fitzgerald C; Segurado R; Kapur K; George S; Bhardwaj N; Linnane B; O'Ceilleachair A; Staines A; Fitzpatrick P J Cyst Fibros; 2024 Sep; 23(5):896-902. PubMed ID: 38964978 [TBL] [Abstract][Full Text] [Related]
12. The Use of Economic Evaluation to Inform Newborn Screening Policy Decisions: The Washington State Experience. Grosse SD; Thompson JD; Ding Y; Glass M Milbank Q; 2016 Jun; 94(2):366-91. PubMed ID: 27265561 [TBL] [Abstract][Full Text] [Related]
13. Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007. Briesacher BA; Quittner AL; Fouayzi H; Zhang J; Swensen A Pediatr Pulmonol; 2011 Aug; 46(8):770-6. PubMed ID: 21465674 [TBL] [Abstract][Full Text] [Related]
15. Understanding the costs of care for cystic fibrosis: an analysis by age and health state. van Gool K; Norman R; Delatycki MB; Hall J; Massie J Value Health; 2013; 16(2):345-55. PubMed ID: 23538187 [TBL] [Abstract][Full Text] [Related]
16. A Low-Cost and Simple Genetic Screening for Cystic Fibrosis Provided by the Brazilian Public Health System. Rispoli T; Martins de Castro S; Grandi T; Prado M; Filippon L; Dornelles da Silva CM; Vargas JE; Rossetti LMR J Pediatr; 2018 Aug; 199():272-277.e3. PubMed ID: 29731357 [TBL] [Abstract][Full Text] [Related]
17. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: a 10-year retrospective study in a French region (Brittany). Siret D; Bretaudeau G; Branger B; Dabadie A; Dagorne M; David V; de Braekeleer M; Moisan-Petit V; Picherot G; Rault G; Storni V; Roussey M Pediatr Pulmonol; 2003 May; 35(5):342-9. PubMed ID: 12687590 [TBL] [Abstract][Full Text] [Related]
18. Benefits of newborn screening for cystic fibrosis in Shreveport, Louisiana, Cystic Fibrosis Center. Venkata JA; Jones KL J La State Med Soc; 2011; 163(6):316-9. PubMed ID: 22324090 [TBL] [Abstract][Full Text] [Related]
19. Comparison of the US and Australian cystic fibrosis registries: the impact of newborn screening. Martin B; Schechter MS; Jaffe A; Cooper P; Bell SC; Ranganathan S Pediatrics; 2012 Feb; 129(2):e348-55. PubMed ID: 22250024 [TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome. Ren CL; Desai H; Platt M; Dixon M Pediatr Pulmonol; 2011 Nov; 46(11):1079-84. PubMed ID: 21538969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]